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Summary 
 
1-Keto-1,2,3,4-tetrahydrophenanthrene (THP-1) was  reported by Cook et al in 1933 
as the first synthetic estrogen. Estrogenic activity was assessed by the induction of 
vaginal cornification in ovariectomised rats. The corresponding 4-isomer (THP-4) 
was shown to be inactive. Both chemicals have been re-synthesised and assessed for 
hormonal activity.  Each chemical bound weakly and to the same extent to isolated 
estrogen receptors, but only at high  concentrations. However, they each lacked 
estrogenic or anti-estrogenic activity when evaluated in vitro using a yeast hER assay, 
and both failed to induce vaginal cornification or uterotrophic effects in 
ovariectomised rats. THP-1, and to a lesser extent THP-4,  were shown to possess 
weak androgenic and anti-androgenic activity in vitro when evaluated using an hAR 
yeast assay. Estrogenic activity for bisphenol A (BPA) was subsequently 
demonstrated by Dodds and Lawson (1936)  using the same ovariectomised rat 
protocol, and this activity has been confirmed and supplemented by positive 
uterotrophic effects for BPA in the same bioassays.  
 
The present results illustrate the complexity of deriving conclusions regarding the 
hormonal activities of chemicals. First, some activities observed in isolated hormonal 
receptor binding assays may not be expressed in functional hormonal assays. This 
indicates the need for functional hormonal assays in any screening programme. 
Second, that activities observed for a chemical in one hormonal assay may not be 
reflected in related hormonal assays. This indicates the need to define assay protocols 
with some precision when incorporating them into screening batteries. Finally, that 
some literature reports of hormonal activity for chemicals may not be capable of 
independent confirmation under apparently identical conditions of test. This illustrates 
the need to use lists of hormonally active chemicals with care 
 
Introduction 
 
We noted recently (Ashby 1998) the prescient ideas associated by Cook et al (1933) 
with their demonstration of the first synthetic estrogen. Cook et al had evaluated the 
two tetrahydrophenanthrene compounds THP-1 and THP-4 (for structures see Figure 
1) as possible active analogues of estrone, the main natural estrogen known at that 
time. In their studies ovariectomised rats were exposed to the agents as a single 
subcutaneous (s.c.)  injection, and estrus-inducing activity was determined by 
assessment of vaginal cytology 54h after dosing. THP-1 induced vaginal cornification 
in 50% of the animals at a total dose of 50 mg/rat, and in 100% of the animals at a 
total dose of 100 mg/rat. THP-4 was without activity at the only dose level tested 
(total dose of 50 mg/rat). Three years later, Dodds and Lawson (1936) demonstrated 
similar effects on vaginal cytology for bisphenol A (BPA), but by then their test 
protocol had been enlarged to involve twice daily injections of the test agent for three 
days (total dose of 100 mg/rat BPA).  
 
The weakly estrogenic activity of BPA to rodents has since been confirmed, most 
recently by demonstration of the uterotrophic activity of this same total dose of BPA 
in the immature rat (Ashby and Tinwell 1999). However, the activity of THP-1 has 
not hitherto been re-evaluated. The chemical structure of THP-1 is only loosely 
related to that of estradiol; in particular, it bears no phenolic substituent, a 
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characteristic of most synthetic estrogens. It therefore became of interest to re-
synthesise THP-1 and THP-4 (Haworth 1933) in order to confirm their relative 
estrogenicity. The activity of both chemicals in the ovariectomised rat has been re-
evaluated using vaginal cornification and uterotrophic activity as the criteria of 
estrogenicity. The activity of both chemicals in the yeast hER and hAR agonist and 
antagonist assays, as described by Sohoni and Sumpter (1998), was also evaluated.  
 
The lack of functional estrogenic activity for both of the phenanthrenes in the present 
studies led to repetition of a similar ovariectomised rat experiment performed on BPA 
by Dodds and Lawson (1936), with extension of the protocol to include the 
uterotrophic endpoint. 
 
 
Methods 
 
Chemicals 1,2,3,4-tetrahydrophenanthren-1-one (THP-1) and 1,2,3,4-tetrahydro-
phenanthren-4-one (THP-4) were synthesised by the method described by Haworth 
(1933). THP-1 had mp 93.6-94.3oC [Haworth (1933) reports mp 95-96oC]. NMR 
spectroscopy (400MHz, CDCl3) confirmed the structure and indicated the presence of 
about 3% of the THP-4. THP-4 had mp 66-67oC [Haworth (1933) reported mp 69oC]. 
NMR spectroscopy (400MHz, CDCl3) confirmed the structure and indicates the 
presence of about 5% of THP-1. In each case C and H content was found to be within 
0.2% of the calculated values. Estradiol (E2), dihydrotestosterone (DHT), 4-
hydroxytamoxifen and flutamide were purchased from Sigma Chemical Company 
Ltd. (Poole, Dorset, UK). Bisphenol-A (BPA, purity > 99%) was supplied by Aldrich 
Chemical Company, Gillingham, Dorset, UK. [2,4,6,7-3H]oestradiol (88Ci/mmole) 
was obtained from Amersham Pharmacia Biotech UK Ltd, Bucks, UK. 
 
Competitive Binding Assay  Uterine post-microsomal supernatant, isolated from the 
tissue of immature female Alpk:APfSD rats (21-25 days old) was used as a source of 
cytosolic ER in a competitive binding assay as previously described (Shelby et al, 
1996; Ashby et al, 1999). Cytosol extracts were incubated with [2,4,6,7-3H]oestradiol 
(5nM) and varying concentrations of unlabelled putative competitors (0.5nM-5μM 
E2; 5nM-500μM THP 1 and 4) at 4oC for 18h. The precipitated receptor complex  was 
extensively washed in buffer before being suspended in Optiphase-MP scintillant 
(LKB Scintillation Products) and the radioactivity determined a described earlier 
(Ashby et al 1999). 
 
Yeast Assays  Details of the yeast human estrogen receptor (hER) and human 
androgen receptor (hAR) agonist and antagonist assays have been described 
previously (Sohoni and Sumpter, 1998). In outline, the DNA sequence of hER or hAR 
is integrated stably into the yeast genome and associated with an estrogen or androgen 
responsive expression system linked to β-galactosidase. When an estrogenic or 
androgenic ligand is bound to the receptor, β-galactosidase is synthesised which 
catalyses the conversion of the yellow assay detector substrate to a red product. For 
the antagonistic assays, E2 or DHT (the main natural ligands for hER and hAR, 
respectively) are added to the medium at a concentration which gives a sub-maximal 
stimulatory response (E2 at 2.5x10-10M or DHT at 2.5x10-9). Chemicals which are 
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able to inhibit the activity of the these natural ligands lead to a dose-dependent 
decrease in β-galactosidase expression and a reduction in the rate of  formation of the 
red product. Both test chemicals were assayed at least twice in each of the 4 types of 
yeast-based assay and representative data are shown. 
 
Animal studies Alpk:APfSD (Wistar derived) rats were obtained from the 
AstraZeneca breeding unit (Alderley Park). Animal studies were performed in 
accordance with the UK “Animals (Scientific Procedures) Act”. Animal care and 
procedures were carried out according to in-house standards and as described 
previously (Ashby et al. 1997). Rats were ovariectomized at 6-8 weeks of age and 
used after a 2 week recovery period. All administrations were by subcutaneous (s.c.) 
injection in either  arachis oil (AO, as used in our earlier studies) or sesame oil (as 
used by Cook et al 1933 and Dodds and Lawson 1936). The ovariectomized rat 
uterotrophic assays were carried out as described previously (Ashby et al. 1997) with 
the additional observation of vaginal smears, as described below.  
 
Four studies were conducted. The first represented a small modification of the 
experiments described by Cook et al. (1933)   for THP-1 and THP-4, with E2 as a 
positive control agent. In the second and third experiments the precise experimental 
conditions used by Cook et al. (1933)  were used, with the uterotrophic endpoint 
added. The final experiment represented an exact repeat of the vaginal cornification 
study reported by Dodds and Lawson (1936) for BPA, also with the uterotrophic 
endpoint added. Vaginal smears were taken daily from all animals and at termination. 
All animals were killed 72 h after the first (or only) dose of test agent. Quantification 
of vaginal cornification was determined on the terminal smears as described 
previously (Routledge et al, 1998).  
 
Experiment 1 
Rats received either THP-1 or THP-4  (50 mg/rat, s.c) on three consecutive days, or 
100 mg/rat of either chemical as a single s.c dose. The vehicle control group received 
AO alone (0.75 ml/rat, s.c for 3 days) and the positive control group received E2 
(0.011 mg in 0.75 ml AO /rat, s.c for 3 days or 0.022 mg in 1.5 ml AO/rat, s.c as a 
single dose). In this experiment the vehicle and fixed dose volumes were extrapolated 
from the dose volume of 5ml/kg/day for 3 days used in our previous studies 
(Routledge et al, 1998). The dose volume for the single dose group was doubled 
because of solubility problems with THP 1 & 4. The fixed doses of E2/rat were also 
based on previous studies where 0.04 mg/kg/day E2 was used as an s.c. positive 
control agent (Routledge et al, 1998) and was doubled for the single dose group. 
 
Experiments 2 and 3 
Rats received THP-1 (100 mg/rat, s.c) or THP-4 (50 mg/rat, s.c) dissolved in sesame 
oil (2.0 ml/rat) as a single dose split between 2 sites. The control group received 
sesame oil alone (2.0 ml/rat, s.c) and the positive control group received 0.022 mg 
E2/rat, s.c in 2.0 ml sesame oil/rat as a single dose. 
 
Experiment 4 
Rats received BPA at a total dose of 100 mg/rat, s.c (over 3 days) in sesame oil (total 
volume of 3.0 ml sesame oil) administered twice daily (0.5 ml/dose) for 3 days. The 
control group received sesame oil twice daily (0.5 ml/rat/dose, s.c) and the positive 
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control group received E2 at a total dose  of 0.034 mg/rat, s.c (over 3 days), 
administered twice daily for 3 days in sesame oil.  
 
Statistical analysis of data Analysis of variance was determined using the GLM 
procedure described in SAS (1989). Differences from control values in all cases were 
assessed statistically using a 2-sided Student’s t-test based on the error mean square 
from the analysis of variance. 
 
Results  
 
Competitive binding Assays   Representative ER  binding data are illustrated in the 
Figure 2. Both THP-1 and THP-4 were relatively weak ER ligands, competing with 
3H-E2  only at high concentrations. There was little difference between the relative 
affinities of  the two compounds. 
 
Yeast Assays THP-1 and THP-4 were inactive in the hER estrogen and anti-estrogen 
screens (Figure 3A and 3B). The estrogen E2 and the antiestrogen 4-
hydroxytamoxifen acted as positive control agents for these two sets of experiments, 
respectively. Although the results (Figure 3B) seem to suggest that both test 
chemicals were weakly anti-oestrogenic at very high concentrations (above 1x10-5M), 
in fact the results probably indicate a degree of toxicity of the test chemicals to the 
yeasts at these high concentrations. Turbidity of the medium was measured at the end 
of each assay, as an indirect measure of yeast cell number.  This showed reduced 
turbidity in the wells containing high concentrations of both test chemicals, indicating 
that the yeast cells did not divide as rapidly in these wells.  As yeast cell number 
affects the degree and rate of response of the assay to active chemicals (see Beresford 
et al, 2000, for a full discussion of this point), the results probably do not suggest that 
the test chemicals are weakly anti-oestrogenic, but rather that they are toxic (to yeast 
cells) at concentrations above about 1x10-10M.  In contrast, THP-1 was clearly 
androgenic and THP-4 showed marginal androgenic activity (Figure 4A). Both THP-1 
and THP-4 showed dose-related anti-androgenic activity comparable with that of the 
positive control, flutamide (Figure 4B). The androgen DHT and the antiandrogen 
flutamide acted as positive control agents for these two sets of experiments, 
respectively. 
 
Ovariectomised rat assays. THP-1 and THP-4 were tested in three ovariectomised rat 
assays and were without either uterotrophic activity or estrus-inducing (vaginal 
cornification) activity (Table 1). The conditions of test involved the precise 
conditions used by Cook et al (1933; Expts. 2 and 3) where full vaginal cornification 
was observed 54 h after dosing and persisted for 150 h. In our experiments vaginal 
smears were examined 24, 48, 54 and 72 h after the first (or only) dose, but neither 
THP-1 nor THP-4 produced any increase in vaginal cornification at any timepoint 
(data only shown for 72 h; Table 1). 
 
In contrast, when tested under the same conditions as those described by Dodds and 
Lawson (1936), BPA elicited both uterotrophic and estrus-inducing activity (Table 1).  
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Discussion 
 
Cook et al (1933) did not specify the source of their samples of THP-1 and THP-4 
(Figure 1). However, they were probably donated by Haworth who described their 
synthesis that same year (Haworth 1933). NMR analysis of the present samples 
revealed that each was contaminated by ~5% of the alternative isomer, however, they 
are each of the same melting point as described by Haworth (1933) and can be 
considered to be the same as the samples used by Cook et al (1933). Further, the 
activity of each isomer was similar when activity was seen, and that eliminates the 
chance that the contaminant isomer was dominating the activity of the other isomer. 
Both chemicals bound equally and weakly to isolated estrogen receptors (Figure 2), 
but both were without functional activity as estrogens or anti-estrogens in vitro or in 
vivo (Table 1 and Figure 3). This unexpected finding led to re-evaluation of BPA in 
the ovariectomised rat, as described by Dodds and Lawson (1936). The activity 
observed for BPA (Table 1), coupled to its established activity as an estrogen in the 
present yeast hER assay (Sohoni and Sumpter 1998) and the immature rat 
uterotrophic assay (Tinwell and Ashby 1999) indicates that our vaginal cornification 
assay was of similar sensitivity to the assay used by Cook et al to evaluate THP-1 
(Cook et al 1933, Dodds and Lawson 1936). 
 
Sohoni and Sumpter (1998) have shown that some chemicals that show activity as 
estrogens in the yeast hER assay also elicit anti-androgenic activity in the 
corresponding hAR assay.  THP-1 showed AR agonist and antagonist activity, with 
reduced levels of activity for THP-4.  Shortage of the test chemicals prevented further 
evaluation of these activities in rodents.  
 
In summary, THP-1, reported by Cook et al to be the first synthetic estrogen, has been 
shown to lack functional estrogenic activity in vitro and in vivo, but to possess 
androgenic and anti-androgenic activity in vitro. THP-4, reported by Cook et al not to 
be estrogenic in vivo, has been confirmed to be non-estrogenic both in vitro and in 
vivo and to possess weak androgenic and anti-androgenic activity in vitro. Both 
chemicals bound equally and weakly to isolated estrogen receptors. 
 
The present results illustrate the complexity of deriving conclusions regarding the 
hormonal activities of chemicals. First, some activities observed in isolated hormonal 
receptor binding assays may not be expressed in functional hormonal assays. This 
indicates the need for functional hormonal assays in any screening programme. 
Second, that activities observed for a chemical in one hormonal assay may not be 
reflected in related hormonal assays. This indicates the need to define assay protocols 
with some precision when incorporating them into screening batteries. Finally, that 
some literature reports of hormonal activity for chemicals may not be capable of 
independent confirmation under apparently identical conditions of test. This illustrates 
the need to use lists of hormonally active chemicals with care 
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FIGURE 1.Structures of the chemicals discussed in the text. 
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FIGURE 2:  Relative binding affinity of THP-1 and THP-4 to isolated estrogen 
receptors derived from rat uterine cytosol. Estradiol is shown as reference agent.  
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FIGURE 3: Estrogenic (A) and anti-estrogenic (B) activity of THP-1 (  ) and THP-4 
( ) in the yeast hER screen. Blank wells contained solvent only ( ). E2 and 4-
hydroxytamoxifen (  ; OH-tam) were used as  positive controls in A and B 
respectively. In B, E2 was present in all wells (except blanks) at a single concentration 
of 2.5 x 10-10M, E2-blanks ( ) contained E2 only. Values are the means of duplicate 
wells taken from a representative experiment. Both THP-1 and THP-4 were 
concluded to lack either estrogenic or anti-estrogenic activity. 
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FIGURE 4: Androgenic (A) and anti-androgenic (B) activity of THP-1 (  ) and THP-
4 (  ) in the yeast hAR screen. Blank wells contained solvent only (  ). DHT and 
flutamide (  ) were used as  positive controls in A and B respectively. In B, DHT was 
present in all wells (except blanks) at a single concentration of 2.5 x 10-9M, DHT-
blanks () contained DHT only. Values are the means of duplicate wells taken from 
a representative experiment. 
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Compound Dose/rat and duration 
of dosing 
Uterus wet 
weight (mg)
Uterus dry 
weight (mg)
Vaginal 
cornification 
(% cornified 
cells) 
Initial body 
weight (g) 
Final body 
weight (g) 
EXPERIMENT 1 
Arachis oil 0.75 ml/day for 3 
days 
68.8±6.4  
(6) 
16.6±1.5 18.5±5.7 288.2±19.5 300.0±21.7 
THP-1 50 mg/day  for 3 
days 
72.0±11.3 
(7) 
17.2±2.7 17.8±10.1 277.3±14.7 283.0±15.4 
THP-1 100 mg/day for 1 day 65.0±6.3 
(7) 
15.8±1.6 21.9±13.4 277.6±14.2 285.4±16.2 
THP-4 50 mg/day  for 3 
days  
69.1±10.5 
(7) 
16.8±2.7 8.9±8.6 273.0±21.3 275.6±24.5 
THP-4 100 mg/day for 1 day 63.7±7.6 
(6) 
15.1±1.8 16.5±7.2 273.7±16.4 276.3±20.2 
E2 0.011mg/day for 3 
days 
231.6±32.2*
* 
(3) 
44.5±6.5** 100±0** 286.0±8.0 292.0±12.0 
E2 0.022 mg/day for 1 
day 
144.2±5.5**
(3) 
29.6±0.7** 100±0** 286.0±8.2 289.7±6.8 
EXPERIMENT 2 
Sesame oil 2.0 ml/day for 1 day 70.7±8.8 
(6) 
16.2±2.0 18.9±4.7 269.0±20.3 284.0±22.9 
THP-1 100 mg/day for 1 day 68.8±4.7 
(4) 
16.2±2.2 20.0±5.6 266.8±18.1 278.3±17.1 
THP-4 50 mg/day for 1 day 71.3±7.7 
(5) 
16.2±1.5 15.2±6.9 264.0±8.8 277.6±11.2 
E2 0.022 mg/day for 1 
day 
127.4±4.9**
(3) 
25.9±0.6 100.0±0** 265.3±10.5 267.3±9.7 
EXPERIMENT 3 
Sesame oil 2.0 ml/day for 1 day 67.7±9.5 
(7) 
15.5±2.0 11.5±3.9 279.8±18.6 296.1±18.2 
THP-1 100 mg/day for 1 day 67.1±5.5 
(4) 
15.6±1.6 12.6±5.4 289.8±13.7 307.5±16.3 
THP-4 50 mg/day for 1 day 70.2±11.9 
(5) 
16.4±2.4 17.3±7.0 283.0±12.4 296.2±13.3 
E2 0.022 mg/day for 1 
day 
115.5±4.8**
(3) 
23.2±0.7** 100±0** 284.3±11.4 293.0±9.8 
EXPERIMENT 4 
Sesame oil 0.5 ml/dose, twice 
daily, for 3 days 
70.9±12.9  
(7) 
15.8±3.1 8.2±3.0 279.5±13.4 295.3±14.0 
BPA 16.7 mg/dose, twice 
daily, for 3 days 
135.6±24.4*
* (7) 
26.8±5.9** 100±0** 281.8±24.1 291.4±25.0 
E2 0.0056 mg/dose, 
twice daily, for 3 
days 
221.9±3.5** 
(3) 
40.8±1.2** 100±0** 293.7±14.5 296.7±14.7 
 
TABLE 1. The effect of  THP-1, THP-4 and BPA on uterus weights and vaginal 
cornification (% cornified cells present in the vaginal smear). Estradiol (E2) was used 
as a positive control. Compounds were administered s.c. in oil (arachis or sesame as 
specified). Animals were killed 72h after the first (or only) dose. The vaginal 
cornification data shown were determined at sacrifice. Data are mean ± SD, values in 
parentheses are numbers of animals, which were the same for all determinations. * p< 
0.05, ** p< 0.01. 
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